133 related articles for article (PubMed ID: 9730230)
1. Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor.
Manetti F; Cappello V; Botta M; Corelli F; Mongelli N; Biasoli G; Borgia AL; Ciomei M
Bioorg Med Chem; 1998 Jul; 6(7):947-58. PubMed ID: 9730230
[TBL] [Abstract][Full Text] [Related]
2. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
[TBL] [Abstract][Full Text] [Related]
3. New sulfonated distamycin A derivatives with bFGF complexing activity.
Ciomei M; Pastori W; Mariani M; Sola F; Grandi M; Mongelli N
Biochem Pharmacol; 1994 Jan; 47(2):295-302. PubMed ID: 7508230
[TBL] [Abstract][Full Text] [Related]
4. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
5. Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.
Pesenti E; Sola F; Mongelli N; Grandi M; Spreafico F
Br J Cancer; 1992 Aug; 66(2):367-72. PubMed ID: 1380282
[TBL] [Abstract][Full Text] [Related]
6. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions.
Braddock PS; Hu DE; Fan TP; Stratford IJ; Harris AL; Bicknell R
Br J Cancer; 1994 May; 69(5):890-8. PubMed ID: 7514028
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
[TBL] [Abstract][Full Text] [Related]
8. Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model.
Davol PA; Garza S; Frackelton AR
Cancer; 1999 Nov; 86(9):1733-41. PubMed ID: 10547546
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of C-8 linked pyrrolobenzodiazepine-naphthalimide hybrids as anti-tumour agents.
Kamal A; Reddy BS; Reddy GS; Ramesh G
Bioorg Med Chem Lett; 2002 Aug; 12(15):1933-5. PubMed ID: 12113812
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the effects of tumor necrosis factor-alpha (TNF-alpha), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo.
Olivo M; Bhardwaj R; Schulze-Osthoff K; Sorg C; Jacob HJ; Flamme I
Anat Rec; 1992 Sep; 234(1):105-15. PubMed ID: 1384395
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis by suramin.
Gagliardi A; Hadd H; Collins DC
Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic and antiproliferative activity of suramin analogues.
Gagliardi AR; Kassack M; Kreimeyer A; Muller G; Nickel P; Collins DC
Cancer Chemother Pharmacol; 1998; 41(2):117-24. PubMed ID: 9443624
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro.
Collin-Osdoby P; Rothe L; Bekker S; Anderson F; Huang Y; Osdoby P
J Bone Miner Res; 2002 Oct; 17(10):1859-71. PubMed ID: 12369790
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin.
Coleman AB; Momand J; Kane SE
Mol Pharmacol; 2000 Feb; 57(2):324-33. PubMed ID: 10648642
[TBL] [Abstract][Full Text] [Related]
15. Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.
Morris AD; Léonce S; Guilbaud N; Tucker GC; Pérez V; Jan M; Cordi AA; Pierré A; Atassi G
Anticancer Drugs; 1997 Sep; 8(8):746-55. PubMed ID: 9396618
[TBL] [Abstract][Full Text] [Related]
16. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane.
Ribatti D; Urbinati C; Nico B; Rusnati M; Roncali L; Presta M
Dev Biol; 1995 Jul; 170(1):39-49. PubMed ID: 7601314
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
[TBL] [Abstract][Full Text] [Related]
18. Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.
Bernardini N; Giannessi F; Bianchi F; Dolfi A; Lupetti M; Citti L; Danesi R; Del Tacca M
Br J Cancer; 1993 Jun; 67(6):1209-16. PubMed ID: 7685616
[TBL] [Abstract][Full Text] [Related]
19. Capillary plexus development in the day five to day six chick chorioallantoic membrane is inhibited by cytochalasin D and suramin.
Melkonian G; Munoz N; Chung J; Tong C; Marr R; Talbot P
J Exp Zool; 2002 Feb; 292(3):241-54. PubMed ID: 11857458
[TBL] [Abstract][Full Text] [Related]
20. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection.
Parsons-Wingerter P; Lwai B; Yang MC; Elliott KE; Milaninia A; Redlitz A; Clark JI; Sage EH
Microvasc Res; 1998 May; 55(3):201-14. PubMed ID: 9657920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
